BMS-247550 in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating women who have
stage IV or recurrent metastatic breast cancer.